Characterization of frontotemporal dementia and/or amyotrophic lateral sclerosis associated with the GGGGCC repeat expansion in C9ORF72
暂无分享,去创建一个
David T. Jones | C. Jack | R. Petersen | B. Boeve | O. Pedraza | T. Ferman | P. Vemuri | D. Knopman | V. Lowe | K. Kantarci | B. Boot | M. Murray | D. Dickson | J. Parisi | J. Whitwell | Anahita Adeli | K. Kuntz | J. Lucas | Z. Wszolek | N. Graff-Radford | M. Baker | J. Adamson | K. Josephs | R. Gavrilova | R. Savica | M. Machulda | J. Fields | N. Rutherford | K. Boylan | Nicola J. Rutherford | R. Rademakers | Andrew Reeves | B. Rush | M. Dejesus‐Hernandez | D. Knopman | Otto Pedraza
[1] M. Nalls,et al. The chromosome 9 ALS and FTD locus is probably derived from a single founder , 2012, Neurobiology of Aging.
[2] T. Hortobágyi,et al. p62 positive, TDP-43 negative, neuronal cytoplasmic and intranuclear inclusions in the cerebellum and hippocampus define the pathology of C9orf72-linked FTLD and MND/ALS , 2011, Acta Neuropathologica.
[3] T. Ferman,et al. Clinical and neuropathologic heterogeneity of c9FTD/ALS associated with hexanucleotide repeat expansion in C9ORF72 , 2011, Acta Neuropathologica.
[4] Bruce L. Miller,et al. Expanded GGGGCC Hexanucleotide Repeat in Noncoding Region of C9ORF72 Causes Chromosome 9p-Linked FTD and ALS , 2011, Neuron.
[5] David Heckerman,et al. A Hexanucleotide Repeat Expansion in C9ORF72 Is the Cause of Chromosome 9p21-Linked ALS-FTD , 2011, Neuron.
[6] Nick C Fox,et al. Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. , 2011, Brain : a journal of neurology.
[7] J. Hodges,et al. Motor neuron dysfunction in frontotemporal dementia. , 2011, Brain : a journal of neurology.
[8] J. Trojanowski,et al. A harmonized classification system for FTLD-TDP pathology , 2011, Acta Neuropathologica.
[9] J. Rohrer. Behavioural Variant Frontotemporal Dementia—Defining Genetic and Pathological Subtypes , 2011, Journal of Molecular Neuroscience.
[10] O. Hardiman,et al. Proposed criteria for familial amyotrophic lateral sclerosis , 2011, Amyotrophic Lateral Sclerosis.
[11] Clifford R. Jack,et al. Antemortem differential diagnosis of dementia pathology using structural MRI: Differential-STAND , 2011, NeuroImage.
[12] B. Miller,et al. Classification of primary progressive aphasia and its variants , 2011, Neurology.
[13] Olivier Piguet,et al. Eating and hypothalamus changes in behavioral-variant frontotemporal dementia , 2011, Annals of neurology.
[14] D. Hernandez,et al. Familial frontotemporal dementia with amyotrophic lateral sclerosis and a shared haplotype on chromosome 9p , 2011, Journal of Neurology.
[15] Howard J. Rosen,et al. Neuroimaging in Dementia , 2011, Neurotherapeutics.
[16] J. Hodges,et al. Neurobehavioral features in frontotemporal dementia with amyotrophic lateral sclerosis. , 2010, Archives of neurology.
[17] B. Boeve,et al. Clinical, neuroimaging and neuropathological features of a new chromosome 9p-linked FTD-ALS family , 2010, Journal of Neurology, Neurosurgery & Psychiatry.
[18] C. van Broeckhoven,et al. Identification of 2 Loci at chromosomes 9 and 14 in a multiplex family with frontotemporal lobar degeneration and amyotrophic lateral sclerosis. , 2010, Archives of neurology.
[19] M. York,et al. Detecting frontotemporal dysfunction in ALS: Utility of the ALS Cognitive Behavioral Screen (ALS-CBS™) , 2010, Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases.
[20] Matthew L Senjem,et al. Distinct anatomical subtypes of the behavioural variant of frontotemporal dementia: a cluster analysis study. , 2009, Brain : a journal of neurology.
[21] D. Dickson,et al. Evaluation of subcortical pathology and clinical correlations in FTLD-U subtypes , 2009, Acta Neuropathologica.
[22] S. Heath,et al. Chromosome 9p-linked families with frontotemporal dementia associated with motor neuron disease , 2009, Neurology.
[23] Facundo Manes,et al. A neuropsychological battery to detect specific executive and social cognitive impairments in early frontotemporal dementia. , 2009, Brain : a journal of neurology.
[24] Xun Hu,et al. Mutations in FUS, an RNA Processing Protein, Cause Familial Amyotrophic Lateral Sclerosis Type 6 , 2009, Science.
[25] J L Haines,et al. Supporting Online Material Materials and Methods Figs. S1 to S7 Tables S1 to S4 References Mutations in the Fus/tls Gene on Chromosome 16 Cause Familial Amyotrophic Lateral Sclerosis , 2022 .
[26] P. Schofield,et al. Pedigree with frontotemporal lobar degeneration – motor neuron disease and Tar DNA binding protein-43 positive neuropathology: genetic linkage to chromosome 9 , 2008, BMC neurology.
[27] B. McConkey,et al. TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis , 2008, Nature Genetics.
[28] Xun Hu,et al. TDP-43 Mutations in Familial and Sporadic Amyotrophic Lateral Sclerosis , 2008, Science.
[29] V. Pankratz,et al. The Mayo Clinic Study of Aging: Design and Sampling, Participation, Baseline Measures and Sample Characteristics , 2008, Neuroepidemiology.
[30] D. Dickson,et al. Hippocampal sclerosis in tau-negative frontotemporal lobar degeneration , 2007, Neurobiology of Aging.
[31] V. Meininger,et al. Three families with amyotrophic lateral sclerosis and frontotemporal dementia with evidence of linkage to chromosome 9p. , 2007, Archives of neurology.
[32] Julie S. Snowden,et al. Heterogeneity of ubiquitin pathology in frontotemporal lobar degeneration: classification and relation to clinical phenotype , 2006, Acta Neuropathologica.
[33] C. Duijn,et al. Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21 , 2006, Nature.
[34] S. Melquist,et al. Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17 , 2006, Nature.
[35] Ronald C Petersen,et al. Clinically undetected motor neuron disease in pathologically proven frontotemporal lobar degeneration with motor neuron disease. , 2006, Archives of neurology.
[36] F. Baas,et al. Familial amyotrophic lateral sclerosis with frontotemporal dementia is linked to a locus on chromosome 9p13.2-21.3. , 2006, Brain : a journal of neurology.
[37] H. Horvitz,et al. A locus on chromosome 9p confers susceptibility to ALS and frontotemporal dementia , 2006, Neurology.
[38] Nick C Fox,et al. Magnetic resonance imaging signatures of tissue pathology in frontotemporal dementia. , 2005, Archives of neurology.
[39] Karl J. Friston,et al. Unified segmentation , 2005, NeuroImage.
[40] David Wechsler,et al. Wechsler Memory scale. , 2005 .
[41] Nick C Fox,et al. Voxel-Based Morphometry in Tau-Positive and Tau-Negative Frontotemporal Lobar Degenerations , 2004, Neurodegenerative Diseases.
[42] C. Lomen‐Hoerth,et al. Characterization of Amyotrophic Lateral Sclerosis and Frontotemporal Dementia , 2004, Dementia and Geriatric Cognitive Disorders.
[43] A. Pestronk,et al. Inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia is caused by mutant valosin-containing protein , 2004, Nature Genetics.
[44] H. Braak,et al. Neuropathological stageing of Alzheimer-related changes , 2004, Acta Neuropathologica.
[45] N. Foster. Validating FDG-PET as a biomarker for frontotemporal dementia , 2003, Experimental Neurology.
[46] Catherine Lomen-Hoerth,et al. The overlap of amyotrophic lateral sclerosis and frontotemporal dementia , 2002, Neurology.
[47] N. Tzourio-Mazoyer,et al. Automated Anatomical Labeling of Activations in SPM Using a Macroscopic Anatomical Parcellation of the MNI MRI Single-Subject Brain , 2002, NeuroImage.
[48] B L Miller,et al. Patterns of brain atrophy in frontotemporal dementia and semantic dementia , 2002, Neurology.
[49] A J Lees,et al. What features improve the accuracy of clinical diagnosis in Parkinson's disease: A clinicopathologic study , 2001, Neurology.
[50] J. J. Ryan,et al. Wechsler Adult Intelligence Scale-III , 2001 .
[51] M. Swash,et al. El Escorial revisited: Revised criteria for the diagnosis of amyotrophic lateral sclerosis , 2000, Amyotrophic lateral sclerosis and other motor neuron disorders : official publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases.
[52] R. Faber,et al. Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. , 1999, Neurology.
[53] K. Lindblad,et al. Expanded Repeat Sequences and Disease , 1999, Seminars in neurology.
[54] E. Tangalos,et al. Normative data for the Mattis Dementia Rating Scale. , 1998, Journal of clinical and experimental neuropsychology.
[55] Ronald C. Petersen,et al. Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17 , 1998, Nature.
[56] E. Tangalos,et al. Mayo's older Americans normative studies: category fluency norms. , 1998, Journal of clinical and experimental neuropsychology.
[57] Bruce L. Miller,et al. Frontal lobe degeneration: clinical, neuropsychological and SPECT characteristics , 1998 .
[58] T. Tombaugh,et al. The 60-item Boston Naming Test: norms for cognitively intact adults aged 25 to 88 years. , 1997, Journal of clinical and experimental neuropsychology.
[59] E. Tangalos,et al. Free and cued selective reminding test: MOANS norms. , 1997, Journal of clinical and experimental neuropsychology.
[60] E. Tangalos,et al. Neuropsychological tests' norms above age 55: COWAT, BNT, MAE token, WRAT-R reading, AMNART, STROOP, TMT, and JLO , 1996 .
[61] R. Mohs,et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). , 1995, Neurology.
[62] C. Clark,et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD) , 1994, Neurology.
[63] J. Haines,et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis , 1993, Nature.
[64] E. Tangalos,et al. Mayo's older americans normative studies: WAIS-R norms for ages 56 to 97 , 1992 .
[65] James F. Malec,et al. Mayo's older americans normative studies: Updated AVLT norms for ages 56 to 97 , 1992 .
[66] R. Mohs,et al. Consortium to establish a registry for Alzheimer's disease (CERAD) clinical and neuropsychological assessment of Alzheimer's disease. , 2002, Psychopharmacology bulletin.
[67] D. Delis,et al. The California verbal learning test , 2016 .
[68] Robert A. Bornstein,et al. Normative data on selected neuropsychological measures from a nonclinical sample , 1985 .
[69] E. Kaplan,et al. The Boston naming test , 2001 .
[70] A. Benton. Contributions to Neuropsychological Assessment: A Clinical Manual , 1983 .
[71] Charles J. Golden,et al. A Manual for the Clinical and Experimental Use of the Stroop Color and Word Test , 1978 .
[72] S. Folstein,et al. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.
[73] A. Aronson. Clinical examinations in neurology , 1971 .
[74] P. Rubé,et al. L’examen Clinique en Psychologie , 1959 .
[75] R. Reitan. Validity of the Trail Making Test as an Indicator of Organic Brain Damage , 1958 .
[76] P. S. Achilles. THE PSYCHOLOGICAL CORPORATION. , 1923, Science.